Full-Time

Senior Bioinformatics Scientist

Solid Tumor DNA Oncology

Posted on 4/30/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$140k - $180kAnnually

+ Incentive Compensation + Restricted Stock Units

Senior, Expert

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
Bioinformatics
Biology & Biotech
Required Skills
Python
R
Data Structures & Algorithms
Requirements
  • Experience with scientific programming, relational data systems, algorithms development, data modeling, and statistical modeling.
  • Leadership experience in NGS pipeline development in a clinical setting.
  • Must have completed a Ph.D. in Cancer Biology or Molecular Biology related to cancer.
  • At least 5+ years of post-doc experience.
  • Computational skills using Python and/or R.
Responsibilities
  • Design and conduct analysis to improve variant calling, classification, and analysis systems.
  • Translate insight from model systems into predictors and classifiers of therapeutic response and prognosis in clinical cancer care.
  • Lead collaborations with scientists, and clinicians to design and perform analyses on cancer clinical sequencing data in order to improve quality of care.
  • Lead an interdisciplinary group of scientists and engineers to translate research into clinically actionable insights for our clients.
  • Develop algorithms used to gain insight into cancer variation through analysis of next-generation sequencing data.
  • Communicate with outside scientific teams as well as product and bioinformatics leadership.
  • Produce high-quality and detailed documentation for all projects.
  • Provide thought leadership and technical expertise for analytical and clinical validation experiments and reports.
  • Plan, review, and guide team members' contributions toward best practices and organizational goals.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where they have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive research with practical applications in patient care and drug development. The goal of Tempus is to improve healthcare delivery and outcomes by leveraging advanced data analysis and AI.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
  • Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
  • Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

What critics are saying

  • Competition from partners like Genialis may lead to conflicts of interest.
  • Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
  • Technical challenges may arise in integration with Flatiron's OncoEMR platform.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids in personalized treatment decisions for cancer patients.
  • Tempus collaborates with biotech firms to enhance drug development using real-world data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

INACTIVE